Long-Term Follow-Up Confirms a Sustained Reduction in Deaths from Prostate Cancer with PSA Screening By Ogkologos - November 4, 2025 308 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ERSPC study Source RELATED ARTICLESMORE FROM AUTHOR Mezigdomide-Carfilzomib-Dexamethasone Prolongs PFS Compared with Carfilzomib-Dexamethasone at First Relapse in Patients with Relapsed Or Refractory Multiple Myeloma FDA Approves Durvalumab in Combination with BCG for High-Risk Non-Muscle Invasive Bladder Cancer Systemic Aging Associated with a Higher Risk of Early-Onset Solid Cancers MOST POPULAR Banking on breakthroughs for children and young people September 27, 2022 Groom Uses Wedding To Ask Stepdaughters If He Can Adopt Them September 10, 2021 Worried Cancer Patients Face Delayed Treatment Because Of Pandemic April 1, 2020 FDA Grants Accelerated Approval to Talquetamab-tgvs for Relapsed or Refractory Multiple... September 15, 2023 Load more HOT NEWS Study Says Gold Particles Injected into Tumors May Improve Cancer Patients’... Ovarian, bowel and non-Hodgkin’s lymphoma treatments approved for NHS use in... For People with Cancer, Are Steroids the Best Treatment for Breathing... Low-Dose Pembrolizumab with Dose-Dense Chemotherapy Increases pCR as Neoadjuvant Treatment for...
